financetom
Business
financetom
/
Business
/
Silvercorp's Offer For Orecorp Lapses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silvercorp's Offer For Orecorp Lapses
Mar 26, 2024 3:39 AM

06:05 AM EDT, 03/26/2024 (MT Newswires) -- Silvercorp Metals Inc. ( SVM ) overnight Monday said it did not satisfy the 50.1% minimum acceptance condition before its off-market takeover bid for all ordinary shares of OreCorp Limited expired March 22.

Silvercorp has elected not to exercise its "right to match" a competing offer for OreCorp, the company said.

Silvercorp will remain entitled to payment of a break fee of about A$2.8 million in certain circumstances.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CAVA Group Fiscal Q2 Earnings Fall, Revenue Rises
CAVA Group Fiscal Q2 Earnings Fall, Revenue Rises
Aug 29, 2024
04:29 PM EDT, 08/22/2024 (MT Newswires) -- CAVA Group ( CAVA ) reported fiscal Q2 earnings late Thursday of $0.17 per diluted share, down from $0.21 a year ago. Analysts polled by Capital IQ expected earnings of $0.12. Revenue for the quarter that ended July 14 was $233.5 million, up from $172.9 million a year earlier. Analysts surveyed by Capital...
Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing
Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing
Aug 29, 2024
04:11 PM EDT, 08/22/2024 (MT Newswires) -- Joshua J. Ofman, President, on August 21, 2024, sold 74,084 shares in Grail (GRAL) for $1,203,650. Following the Form 4 filing with the SEC, Ofman has control over a total of 191,757 shares of the company, with 191,757 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1699031/000162828024038210/xslF345X05/wk-form4_1724356928.xml ...
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Aug 29, 2024
Aug 22 (Reuters) - Bristol-Myers Squibb ( BMY )-backed Zenas BioPharma has filed to go public in the United States, a regulatory filing showed on Thursday, underscoring improving investor appetite for new listings. The U.S. initial public offering market is in the early innings of a recovery on hopes of potential interest-rate cuts and lower market volatility. Zenas BioPharma, an...
--Belden Keeps Quarterly Dividend at $0.05 a Share, Payable on Oct. 8 to Shareholders on Sept. 12
--Belden Keeps Quarterly Dividend at $0.05 a Share, Payable on Oct. 8 to Shareholders on Sept. 12
Aug 29, 2024
04:29 PM EDT, 08/22/2024 (MT Newswires) -- Price: 103.50, Change: -0.58, Percent Change: -0.56 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved